{"response":{"meta":{"hits":35,"time":71,"offset":0},"docs":[{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/12\/11\/business\/11reuters-newedge-socgen-commodities.html","snippet":"Societe Generale's senior base metals trader, Mike Turek, and Natasha Flora, an energy trader, left the bank in New York on Thursday, as part of a wider retrenchment following the French bank's takeover of Newedge, two sources told Reuters.","lead_paragraph":"Societe Generale's senior base metals trader, Mike Turek, and Natasha Flora, an energy trader, left the bank in New York on Thursday, as part of a wider retrenchment following the French bank's takeover of Newedge, two sources told Reuters.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Newedge Metal, Energy Traders Leave as SocGen Cuts Headcount","print_headline":"Newedge Metal, Energy Traders Leave as SocGen Cuts Headcount"},"keywords":[],"pub_date":"2014-12-11T17:24:06Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"548a19e17988102fcc1300ea","word_count":"333"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/11\/28\/business\/28reuters-merck-consumers.html","snippet":"Merck KGaA aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion (0.63 billion pounds) for the German drugs and chemicals company.","lead_paragraph":"Merck KGaA aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion (0.63 billion pounds) for the German drugs and chemicals company.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Germany's Merck Aims to Grow, Not Sell $1 Billion Consumer Health Arm","print_headline":"Germany's Merck Aims to Grow, Not Sell $1 Billion Consumer Health Arm"},"keywords":[],"pub_date":"2014-11-28T09:24:55Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"5478867679881006dca8c3c1","word_count":"375"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/11\/04\/business\/04reuters-stocks-investment-founders-insight.html","snippet":"For good stock market bets, some top investors can't be too bothered by details like corporate profits: instead, they pick companies run by their founders.","lead_paragraph":"For good stock market bets, some top investors can't be too bothered by details like corporate profits: instead, they pick companies run by their founders.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Insight-Top Investors Stay Loyal to Big Name Corporate Founders","print_headline":"Insight-Top Investors Stay Loyal to Big Name Corporate Founders"},"keywords":[],"pub_date":"2014-11-04T15:50:16Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54593c6a79881027068435e0","word_count":"1004"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/24\/business\/24reuters-unipharm-m-a-exclusive.html","snippet":"Over-the-counter drugmaker Unipharm is up for sale and has hired advisory firm Houlihan Lokey to explore a deal that could value it at around $500 million (310.83 million pounds), three sources familiar with the matter told Reuters.","lead_paragraph":"Over-the-counter drugmaker Unipharm is up for sale and has hired advisory firm Houlihan Lokey to explore a deal that could value it at around $500 million (310.83 million pounds), three sources familiar with the matter told Reuters.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Exclusive-Unipharm Hires Houlihan Lokey to Explore $500 Million Sale - Sources","print_headline":"Exclusive-Unipharm Hires Houlihan Lokey to Explore $500 Million Sale - Sources"},"keywords":[],"pub_date":"2014-10-24T14:04:20Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"544a9545798810574ee7c4c7","word_count":"563"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/20\/business\/20reuters-sigma-tau-m-a-alfa.html","snippet":"Italian drugmaker Sigma-Tau is in advanced talks to sell part of its Italian operations to domestic peer Alfa Wassermann that would create an over-the-counter (OTC) powerhouse, several sources familiar with the situation said.","lead_paragraph":"Italian drugmaker Sigma-Tau is in advanced talks to sell part of its Italian operations to domestic peer Alfa Wassermann that would create an over-the-counter (OTC) powerhouse, several sources familiar with the situation said.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Sigma-Tau, Alfa Wassermann in Talks to Combine Italian Operations- Sources","print_headline":"Sigma-Tau, Alfa Wassermann in Talks to Combine Italian Operations- Sources"},"keywords":[],"pub_date":"2014-10-20T15:47:17Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54456766798810347c1a833f","word_count":"653"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/15\/business\/15reuters-clearing-derivatives-rules.html","snippet":"Clearing houses that help make trading derivatives safer will have to spell out how they would recover from a crisis without needing taxpayer bailouts, new rules from global regulators said on Wednesday.","lead_paragraph":"Clearing houses that help make trading derivatives safer will have to spell out how they would recover from a crisis without needing taxpayer bailouts, new rules from global regulators said on Wednesday.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"New Rules to Stop Clearers Becoming 'Too Big to Fail'","print_headline":"New Rules to Stop Clearers Becoming 'Too Big to Fail'"},"keywords":[],"pub_date":"2014-10-15T12:27:02Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"543ea18579881001751bf4a4","word_count":"401"},{"web_url":"http:\/\/parenting.blogs.nytimes.com\/2014\/10\/08\/an-over-the-counter-at-home-conception-aid\/","snippet":"Women exploring conception aids have a new option: The Stork OTC, an over-the counter cervical cap designed to collect sperm after intercourse.","lead_paragraph":null,"abstract":"Women exploring conception aids have a new option: The Stork OTC, an over-the counter cervical cap designed to collect sperm after intercourse.","print_page":null,"blog":[],"source":"The New York Times","multimedia":[{"subtype":"wide","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbWide.jpg","height":126,"width":190,"legacy":{"wide":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbWide.jpg","wideheight":"126","widewidth":"190"},"type":"image"},{"subtype":"xlarge","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-articleLarge.jpg","height":265,"width":600,"legacy":{"xlargewidth":"600","xlarge":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-articleLarge.jpg","xlargeheight":"265"},"type":"image"},{"subtype":"thumbnail","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbStandard.jpg","height":75,"width":75,"legacy":{"thumbnailheight":"75","thumbnail":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbStandard.jpg","thumbnailwidth":"75"},"type":"image"}],"headline":{"main":"An Over-the Counter At-Home Conception Aid","kicker":"Motherlode"},"keywords":[{"value":"Artificial Insemination","name":"subject","rank":"1"},{"value":"Infertility","name":"subject","rank":"2"},{"value":"Parenting","name":"subject","rank":"3"},{"value":"Pregnancy and Childbirth","name":"subject","rank":"4"},{"value":"Sperm","name":"subject","rank":"5"}],"pub_date":"2014-10-08T15:44:30Z","document_type":"blogpost","news_desk":"Styles","section_name":"U.S.","subsection_name":null,"byline":{"person":[{"organization":"","role":"reported","rank":1,"firstname":"Kj","lastname":"DELL'ANTONIA"}],"original":"By KJ DELL'ANTONIA"},"type_of_material":"Blog","_id":"5435946b798810520e354ade","word_count":"274"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/08\/business\/08reuters-novartis-moves.html","snippet":"Swiss drugmaker Novartis AG said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline and Eli Lilly to divest three units.","lead_paragraph":"Swiss drugmaker Novartis AG said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline and Eli Lilly to divest three units.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Novartis Says Three Executives to Leave After GSK, Lilly Deals","print_headline":"Novartis Says Three Executives to Leave After GSK, Lilly Deals"},"keywords":[],"pub_date":"2014-10-08T01:34:56Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"5434cd8c79881017f2d284d9","word_count":"244"},{"web_url":"http:\/\/dealbook.nytimes.com\/2014\/09\/15\/greed-continues-to-fuel-penny-stock-frauds\/","snippet":"Fraud in the market for penny stocks continues unabated, two criminal cases filed last week show, Peter J. Henning writes in the White Collar Watch column.","lead_paragraph":null,"abstract":"Fraud in the market for penny stocks continues unabated, two criminal cases filed last week show, Peter J. Henning writes in the White Collar Watch column.","print_page":null,"blog":[],"source":"The New York Times","multimedia":[{"width":190,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbWide.jpg","height":126,"subtype":"wide","legacy":{"wide":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbWide.jpg","wideheight":"126","widewidth":"190"},"type":"image"},{"width":600,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-articleLarge.jpg","height":400,"subtype":"xlarge","legacy":{"xlargewidth":"600","xlarge":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-articleLarge.jpg","xlargeheight":"400"},"type":"image"},{"width":75,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbStandard.jpg","height":75,"subtype":"thumbnail","legacy":{"thumbnailheight":"75","thumbnail":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbStandard.jpg","thumbnailwidth":"75"},"type":"image"}],"headline":{"main":"Greed Continues to Fuel Penny Stock Frauds ","kicker":"DealBook"},"keywords":[{"rank":"1","name":"organizations","value":"Cynk Technology Corp"},{"rank":"1","name":"subject","value":"Frauds and Swindling"},{"rank":"2","name":"subject","value":"Regulation and Deregulation of Industry"},{"rank":"3","name":"subject","value":"Securities and Commodities Violations"}],"pub_date":"2014-09-15T12:03:39Z","document_type":"blogpost","news_desk":"Business","section_name":"Business Day","subsection_name":"Dealbook","byline":{"person":[{"firstname":"Peter","middlename":"J.","lastname":"HENNING","rank":1,"role":"reported","organization":""}],"original":"By PETER J. HENNING"},"type_of_material":"Blog","_id":"54170e9d79881018c378ee16","word_count":"1077"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/09\/11\/business\/11reuters-financial-regulations-swaps.html","snippet":"Tensions are growing between regional regulators over a proposal on collateral requirements that would make it more costly for Asian companies to trade with European banks in off-exchange derivatives -- the often complex financial products used to...","lead_paragraph":"Tensions are growing between regional regulators over a proposal on collateral requirements that would make it more costly for Asian companies to trade with European banks in off-exchange derivatives -- the often complex financial products used to hedge against price swings in underlying assets ranging from interest rates to commodities.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"EU's OTC Derivatives Proposals Threaten Asian Regulatory Clash","print_headline":"EU's OTC Derivatives Proposals Threaten Asian Regulatory Clash"},"keywords":[],"pub_date":"2014-09-11T07:49:11Z","document_type":"article","news_desk":null,"section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54118cd379881060c5af945d","word_count":"1140"}]},"status":"OK","copyright":"Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}